Trials / Completed
CompletedNCT02238249
Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria
Post Marketing Surveillance of Alesion® (Epinastine Hydrochloride) Dry Syrup -Special Drug Use-Results Survey of Alesion® Dry Syrup-
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 122 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Study to investigate the safety and efficacy of Alesion® Dry Syrup under the proper use in daily clinical practice in Japanese paediatric patients with urticaria
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alesion® | Dry Syrup |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2007-09-01
- First posted
- 2014-09-12
- Last updated
- 2014-09-12
Source: ClinicalTrials.gov record NCT02238249. Inclusion in this directory is not an endorsement.